Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000947871-25-001041
Filing Date
2025-11-24
Accepted
2025-11-24 20:22:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3278
  Complete submission text file 0000947871-25-001041.txt   4902
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: 144

Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Subject) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42504 | Film No.: 251514793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)